Cargando…
Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease
INTRODUCTION: Hydroxyurea (HU) is a drug that targets the underlying pathophysiology of sickle cell disease (SCD); however, it continues to be an underutilized treatment for adults. Previous research suggests that HU treatment can result in fewer hospital contacts for acute vaso-occlusive pain crise...
Autores principales: | Letzen, Janelle E., Lanzkron, Sophie, Bond, Kasey, Carroll, Christopher Patrick, Haythornthwaite, Jennifer A., Nance, Sabrina, Campbell, Claudia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455681/ https://www.ncbi.nlm.nih.gov/pubmed/31041423 http://dx.doi.org/10.1097/PR9.0000000000000724 |
Ejemplares similares
-
Multiple Levels of Suffering: Discrimination in Health-Care Settings is Associated With Enhanced Laboratory Pain Sensitivity in Sickle Cell Disease
por: Mathur, Vani A., et al.
Publicado: (2016) -
Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002) -
COVID-19 outcomes in sickle cell disease and sickle cell trait
por: Christian, Jana, et al.
Publicado: (2022) -
Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006) -
Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)